Tissue characterization and calcification potential of commercial bioprosthetic heart valves.

BACKGROUND Tissue properties may contribute to intrinsic calcification of bioprosthetic heart valves. Phospholipids have been proposed as potential nucleation sites for calcification. Other tissue properties might also be important in calcification. METHODS Commercial and control bioprosthetic valve tissues were characterized by shrinkage temperature, moisture content, free amine content, phospholipid content, and calcification level after 90-day rat subcutaneous implantation as described. RESULTS Shrinkage temperature, moisture content, and free amine content were typical for glutaraldehyde-cross-linked tissues. Phospholipid and calcium levels varied considerably among valve types. There was a significant correlation between phospholipid levels and calcification (r = 0.63, p = 0.04). Sulzer Carbomedics Mitroflow and Toronto SPV valve tissues had significantly more calcification than other commercial bioprostheses in this study (p < 0.01). Carpentier-Edwards Duraflex, CE SAV, and CE PERIMOUNT valve tissues had significantly less calcification than Medtronic Mosaic in this animal model (p < 0.02). CONCLUSIONS Processes that reduce phospholipid levels are associated with reduced calcification in the rat subcutaneous model. Significant differences in calcification level were found among commercially available valves. The clinical significance of these results is unknown.

[1]  J. Buján,et al.  Inhibition of the calcification of porcine valve tissue by selective lipid removal. , 1994, Biomaterials.

[2]  E. Wolner,et al.  Glutaraldehyde affects biocompatibility of bioprosthetic heart valves. , 1992, Surgery.

[3]  M. Fishbein,et al.  Idiopathic restrictive cardiomyopathy. , 1984, Circulation.

[4]  F J Schoen,et al.  Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. , 1999, Journal of biomedical materials research.

[5]  J. Girardot,et al.  Effect of Aoa on Glutaraldehyde-Fixed Bioprosthetic Heart Valve Cusps and Walls: Binding and Calcification Studies , 1994, The International journal of artificial organs.

[6]  A. Carpentier,et al.  Techniques for prevention of calcification of valvular bioprostheses. , 1984, Circulation.

[7]  R. Levy,et al.  Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. , 1997, Circulation.

[8]  J. Castillo-olivares,et al.  Inhibition of bovine pericardium calcification: A comparative study of Al3+ and lipid removing treatments , 1991 .

[9]  W. Roberts,et al.  Pathology of bioprosthetic cardiac valves. , 1987, Human pathology.

[10]  F J Schoen,et al.  Pathology of Substitute Heart Valves: New Concepts and Developments , 1994, Journal of cardiac surgery.

[11]  I. Shapiro,et al.  The phosphatidylinositol‐glycolipid anchor on alkaline phosphatase facilitates mineralization initiation in vitro , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  P. Herijgers,et al.  The influence of stenting on the behavior of amino-oleic acid-treated, glutaraldehyde-fixed porcine aortic valves in a sheep model. , 2000, The Journal of heart valve disease.

[13]  H. Plenk,et al.  New aspects of the degeneration of bioprosthetic heart valves after long-term implantation. , 1992, The Journal of thoracic and cardiovascular surgery.

[14]  F J Schoen,et al.  Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde cross-linked porcine aortic valves. , 1994, Journal of biomedical materials research.